Cognitive Effects and Depression Associated With Taxane-Based Chemotherapy in Breast Cancer Survivors: A Meta-Analysis
Purpose: This meta-analysis provides a longitudinal assessment of depression and cognitive impairment induced by taxane-based chemotherapy in women with breast cancer after 6 months of treatment. We highlighted the incidence and prevalence, the cognitive pattern in neuropsychological studies, and th...
Main Authors: | Eiman Y. Ibrahim, Ilaria Domenicano, Kate Nyhan, Mohamed Elfil, Sarah S. Mougalian, Brenda Cartmel, Barbara E. Ehrlich |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-04-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.642382/full |
Similar Items
-
Synthetic approaches to taxanes
by: Berry, N. M.
Published: (1987) -
Chemobrain: Review of studies assessing cognitive impairment in cancer survivors treated with chemotherapy
by: Sonia López-Santiago, et al.
Published: (2012-01-01) -
Effect of Metformin on Doxorubicin-Induced Memory Dysfunction
by: Ibrahim Alharbi, et al.
Published: (2020-03-01) -
Resveratrol, a natural polyphenol, prevents chemotherapy-induced cognitive impairment: Involvement of cytokine modulation and neuroprotection
by: Dong-Dong Shi, et al.
Published: (2018-06-01) -
Effects of adding taxane to anthracycline-based neoadjuvant chemotherapy in locally advanced breast cancer
by: Azra Rašić, et al.
Published: (2019-02-01)